Stocktoria
CERUS CORP CERS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1997-01-31
CERUS CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -3.7% | -7.1% | -16.1% | -18.1% | -30.7% |
| Net margin | -6.7% | -10.4% | -20.1% | -22.7% | -34.1% |
| FCF margin | 0.5% | 4.2% | -25.6% | -14.7% | -21.8% |
| Return on assets | -7.0% | -10.4% | -19.0% | -19.6% | -22.9% |
| Return on equity | -24.1% | -36.8% | -70.1% | -62.4% | -63.5% |
| Current ratio | 1.73 | 2.39 | 2.14 | 1.45 | 2.38 |
| Revenue growth | 16.1% | 7.8% | -0.8% | 18.1% | 39.6% |
Source: SEC EDGAR filings · CIK 0001020214 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.